1. Evaluating New Therapies in HF

4. Hospitalizations and Healthcare Costs: Need for Reduction in Hospitalizations of HF Patients

5. From HF-Centric Thinking to Patient-Centered Thinking

6. EMPA-REG OUTCOME®: Important Features

7. SPRINT Research Question

8. Prevention Is Challenging to Treat

10. Even Common Therapies Are Underdosed

11. Two New HF Therapies Approved

14. Uptitrate 1 Drug at a Time

15. When to Consider Ivabradine

16. Ivabradine (cont)

19. PARADIGM-HF

20. Failure to Prescribe Newer Agents

21. Cost/Benefit of New Therapy

22. Be Proactive and Reduce Physician Inertia

23. A Multifactorial Approach Is Needed: GWTG-HF Medication Initiation Burden

24. Summary

25. Abbreviations

26. Abbreviations (cont)